An association between body mass index and estimated glomerular filtration rate

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1559-1564

  Kawamoto, Ryuichi ^a   Kohara, Katsuhiko ^b   Tabara, Yasuharu ^b   Miki, Tetsuro ^b   Ohtsuka, Nobuyuki ^a   Kusunoki, Tomo ^a   Yorimitsu, Nobokazu ^a  

^a Seiyo Municipal Nomura Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic kidney disease; Estimated glomerular filtration rate; Overweight; Renal function; Risk factor

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC KIDNEY DISEASE; COMMUNITY LIVING; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; RANDOM SAMPLE; RISK FACTOR;

EID: 55449085187     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1559     Document Type: Article

References (35)

1. Weiner DE, Tighiouart H, Stark PC, et al: Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44: 198-206.
2. Meisinger C, Doring A, Lowel H, KORA Study Group: Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27: 1245-1250.
3. Ishizaka N, Ishizaka Y, Toda E, et al: Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism. Hypertens Res 2007; 30: 1035-1041.
4. Levey AS, Eckardt KU, Tsukamoto Y, et al: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
5. Imai E, Horio M, Iseki K, et al: Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156-163.
6. Adelman RD: Obesity and renal disease. Curr Opin Nephrol Hypertens 2002; 11: 331-335.
7. Rutkowski P, Klassen A, Sebekova K, Bahner U, Heidland A: Renal disease in obesity: the need for greater attention. J Ren Nutr 2006; 16: 216-223.
8. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
9. Praga M, Hernández E, Morales E, et al: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001; 16: 1790-1798.
10. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
11. Levey AS, Coresh J, Greene T, et al, Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
12. Imai E: Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese. Nikkei Medical 2007; 11: 18-19 (in Japanese).
13. Ishizaka N, Ishizaka Y, Toda E, et al: Association between obesity and chronic kidney disease in Japanese: differences in gender and hypertensive status? Hypertens Res 2007; 30: 1059-1064.
14. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
15. Gelber RP, Kurth T, Kausz AT, et al: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46: 871-880.
16. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
17. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876.
18. Reynolds K, Gu D, Muntner P, et al: Body mass index and risk of ESRD in China. Am J Kidney Dis 2007; 50: 754-764.
19. Mokdad AH, Ford ES, Bowman BA, et al: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
20. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 2069-2074.
21. Klag MJ, Whelton PK, Randall BL, et al: Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18.
22. Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S: Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res 2007; 30: 167-174.
23. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND Study Group: Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S21-S24.
24. Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-615.
25. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
26. Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-2022.
27. Drueke T, Witko-Sarsat V, Massy Z, et al: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002; 106: 2212-2217.
28. Mathew B, Patel SB, Reams GP, Freeman RH, Spear RM, Villarreal D: Obesity-hypertension: emerging concepts in pathophysiology and treatment. Am J Med Sci 2007; 334: 23-30.
29. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML: Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 2000; 23: 303-310.
30. Knight SF, Imig JD: Obesity, insulin resistance, and renal function. Microcirculation 2007; 14: 349-362.
31. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM: Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17: 555-560.
32. Honda H, Qureshi AR, Heimburger O, et al: Serum albumin, C-reactive protein, interleukin 6, and fetuin-A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148.
33. Inoue M, Toyokawa S, Miyoshi Y, et al: Degree of agreement between weight perception and body mass index of Japanese workers: MY Health Up Study. J Occup Health 2007; 49: 376-381.
34. Ben-Shlomo Y, Kuh D: A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002; 31: 285-293.
35. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773.